We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+6%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$41.9B
AUM Growth
-$427M
(-1%)
Cap. Flow
-$613M
Cap. Flow
% of AUM
-1.46%
Top 10 Holdings %
Top 10 Hldgs %
26.21%
Holding
592
New
84
Increased
188
Reduced
187
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$444M |
| 2 |
Sea Limited
SE
|
+$314M |
| 3 |
Advanced Micro Devices
AMD
|
+$288M |
| 4 |
Apple
AAPL
|
+$189M |
| 5 |
Qualcomm
QCOM
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$311M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$276M |
| 3 |
Pinterest
PINS
|
+$226M |
| 4 |
NXP Semiconductors
NXPI
|
+$178M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.51% |
| 2 | Healthcare | 20.73% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Financials | 8.95% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Personalis
PSNL
$1.25B
| $2.91M | 0.01% |
151,469
-129,400
| -46% | -$2.71M |
|
327
SOPHiA GENETICS
SOPH
$466M
| $2.84M | 0.01% |
+162,082
| New | +$2.85M |
|
328
Cisco
CSCO
$443B
| $2.7M | 0.01% |
49,526
-9,333
| -16% | -$524K |
|
329
dLocal
DLO
$4.29B
| $2.69M | 0.01% |
+49,223
| New | +$2.75M |
|
|
FLXN
330
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.68M | 0.01% |
+438,619
| New | +$2.73M |
|
|
TPTX
331
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.65M | 0.01% |
39,881
-22,305
| -36% | -$1.59M |
|
332
Cabaletta Bio
CABA
$427M
| $2.61M | 0.01% |
+214,721
| New | +$1.98M |
|
333
Arrowhead Research
ARWR
$12.1B
| $2.61M | 0.01% |
41,803
+15,249
| +57% | +$987K |
|
334
CVS Health
CVS
$135B
| $2.6M | 0.01% |
30,602
| – | – |
|
|
ONEM
335
DELISTED
1Life Healthcare
ONEM
| $2.59M | 0.01% |
127,695
-26,778
| -17% | -$688K |
|
336
Olema Pharmaceuticals
OLMA
$977M
| $2.56M | 0.01% |
+92,785
| New | +$2.5M |
|
337
Coca-Cola
KO
$383B
| $2.51M | 0.01% |
47,892
| – | – |
|
338
Chevron
CVX
$382B
| $2.45M | 0.01% |
24,180
+681
| +3% | +$67.9K |
|
339
Rapid Micro Biosystems
RPID
$102M
| $2.43M | 0.01% |
+131,505
| New | +$2.72M |
|
340
Cytek Biosciences
CTKB
$566M
| $2.42M | 0.01% |
+112,980
| New | +$2.66M |
|
|
RNAM
341
DELISTED
Avidity Biosciences
RNAM
| $2.33M | 0.01% |
+94,805
| New | +$2.06M |
|
|
CNVY
342
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $2.31M | 0.01% |
275,088
+4,138
| +2% | +$36.8K |
|
343
Privia Health
PRVA
$3.04B
| $2.3M | 0.01% |
97,628
+1,543
| +2% | +$53.9K |
|
344
NextEra Energy
NEE
$185B
| $2.11M | 0.01% |
26,910
+835
| +3% | +$67.3K |
|
345
Autodesk
ADSK
$51.8B
| $2.1M | 0.01% |
7,379
-165,721
| -96% | -$50.7M |
|
346
Merck
MRK
$322B
| $2.05M | ﹤0.01% |
27,241
| – | – |
|
347
Larimar Therapeutics
LRMR
$377M
| $2.03M | ﹤0.01% |
+175,870
| New | +$2.11M |
|
348
Bristol-Myers Squibb
BMY
$129B
| $1.89M | ﹤0.01% |
31,929
-252
| -0.8% | -$16.6K |
|
349
Pfizer
PFE
$143B
| $1.87M | ﹤0.01% |
43,512
+1,695
| +4% | +$75.1K |
|
350
Sysco
SYY
$40.8B
| $1.87M | ﹤0.01% |
23,797
-985,016
| -98% | -$75.1M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2021 Portfolio in Review
As of Q3 2021, Fred Alger Management held 592 positions worth $41.9B, down 1% from $42.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Fred Alger Management's Q3 2021 filing shows 84 new, 188 increased, 187 reduced and 80 closed positions. Its largest new stake was Novavax: 621,033 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $311M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fred Alger Management's largest Q3 2021 buy was Novavax: 621,033 shares worth $129M.
- Fred Alger Management added most to Tesla in Q3 2021, an estimated $444M increase.
- Fred Alger Management's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $311M.
- Fred Alger Management fully exited PhenomeX Inc. Common Stock in Q3 2021, selling an estimated $137M.
- Fred Alger Management's ten largest holdings make up 26% of its $41.9B portfolio in Q3 2021.
- Fred Alger Management opened 84 new positions and closed 80 in Q3 2021.
- Fred Alger Management's portfolio value fell 1% quarter-over-quarter to $41.9B.
Based on Fred Alger Management's 13F filing for Q3 2021, filed 15 Nov 2021.